Cancer statistics, 2023
- PMID: 36633525
- DOI: 10.3322/caac.21763
Cancer statistics, 2023
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus-associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.
Keywords: cancer cases; cancer statistics; death rates; incidence; mortality.
© 2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
Similar articles
-
Cancer statistics, 2020.CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. CA Cancer J Clin. 2020. PMID: 31912902
-
Cancer statistics, 2024.CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17. CA Cancer J Clin. 2024. PMID: 38230766
-
Annual report to the nation on the status of cancer, part 1: National cancer statistics.Cancer. 2022 Dec 15;128(24):4251-4284. doi: 10.1002/cncr.34479. Epub 2022 Oct 27. Cancer. 2022. PMID: 36301149 Free PMC article.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
Cited by
-
Disulfidptosis-related gene SLC7A11 predicts prognosis and indicates tumor immune infiltration in lung adenocarcinoma.Transl Cancer Res. 2024 Sep 30;13(9):5064-5072. doi: 10.21037/tcr-24-1182. Epub 2024 Sep 27. Transl Cancer Res. 2024. PMID: 39430814 Free PMC article.
-
Stearoyl CoA desaturase inhibition can effectively induce apoptosis in bladder cancer stem cells.Cancer Cell Int. 2024 Oct 29;24(1):357. doi: 10.1186/s12935-024-03540-w. Cancer Cell Int. 2024. PMID: 39472909 Free PMC article.
-
Prototol for the Prospective Sample Collection for Cancer of Bladder (ProCaB) Trial by the Cancer of the Bladder Leuven (CaBLe) Consortium.Eur Urol Open Sci. 2024 Oct 15;70:21-27. doi: 10.1016/j.euros.2024.09.006. eCollection 2024 Dec. Eur Urol Open Sci. 2024. PMID: 39483518 Free PMC article.
-
LightDPH: Lightweight Dual-Projection-Head Hierarchical Contrastive Learning for Skin Lesion Classification.J Healthc Inform Res. 2024 Oct 1;8(4):619-639. doi: 10.1007/s41666-024-00174-5. eCollection 2024 Dec. J Healthc Inform Res. 2024. PMID: 39463858 Free PMC article.
-
Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy-a systematic review and meta-analysis.Front Oncol. 2024 Oct 17;14:1429386. doi: 10.3389/fonc.2024.1429386. eCollection 2024. Front Oncol. 2024. PMID: 39484040 Free PMC article.
References
REFERENCES
-
- Ghoshal S, Rigney G, Cheng D, et al. Institutional surgical response and associated volume trends throughout the COVID-19 pandemic and postvaccination recovery period. JAMA Netw Open. 2022;5(8):e2227443. doi:10.1001/jamanetworkopen.2022.27443
-
- Yabroff KR, Wu XC, Negoita S, et al. Association of the COVID-19 pandemic with patterns of statewide cancer services. J Natl Cancer Inst. 2022;114(6):907-909.
-
- Chen R, Aschmann HE, Chen YH, et al. Racial and ethnic disparities in estimated excess mortality from external causes in the US, March to December 2020. JAMA Intern Med. 2022;182(7):776-778. doi:10.1001/jamainternmed.2022.1461
-
- Woolf SH, Chapman DA, Sabo RT, Zimmerman EB. Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021. JAMA. 2021;325(17):1786. doi:10.1001/jama.2021.5199
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER Research Data with Delay-Adjustment, 8 Registries, Malignant Only (1975-2019), based on the November 2021 submission. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2022.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
